Page last updated: 2024-12-05

benzyl sulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Benzyl sulfide is a colorless liquid with a pungent odor. It is a sulfur-containing compound that has been studied for its potential use as a precursor to other organic compounds. It can be synthesized by reacting benzyl chloride with sodium sulfide. Benzyl sulfide has been investigated for its biological activity, specifically its effects on the nervous system. It has also been explored as a potential starting material for the synthesis of pharmaceuticals and other useful compounds. The interest in benzyl sulfide stems from its unique chemical properties, such as its ability to undergo nucleophilic reactions, and its potential applications in organic synthesis and medicinal chemistry.'

Cross-References

ID SourceID
PubMed CID10867
CHEMBL ID1369381
SCHEMBL ID206
SCHEMBL ID11075647
MeSH IDM0066301

Synonyms (67)

Synonym
AC-16469
q08048624m ,
unii-q08048624m
smr000112558
MLS002152894
benzyl sulfide
benzyl monosulfide
1,3-diphenyl-2-thiapropane
538-74-9
nsc6648
dibenzyl monosulfide
benzyl thioether
benzene,1'-[thiobis(methylene)]bis-
nsc-6648
dibenzyl sulfide
nsc212544
nsc-212544
dibenzyl thioether
benzylsulfanylmethylbenzene
sulfide,dibenzyl
benzene, 1,1'-[thiobis(methylene)]bis-
inchi=1/c14h14s/c1-3-7-13(8-4-1)11-15-12-14-9-5-2-6-10-14/h1-10h,11-12h
1,1'-[thiobis(methylene)]dibenzene
NCGC00091191-01
einecs 208-703-6
ccris 5969
hsdb 2794
dibenzyl sulphide
1,1'-(thiobis(methylene))bisbenzene
benzene, 1,1'-(thiobis(methylene))bis-
nsc 212544
ai3-00842
sulfide, dibenzyl
dibenzyl sulfide, >=95.0% (hplc)
B0440
AKOS003626437
NCGC00091191-02
cas-538-74-9
dtxsid6024599 ,
NCGC00257880-01
dtxcid704599
tox21_200326
A829811
(phenylmethylthio)methylbenzene
(phenylmethylsulfanyl)methylbenzene
[(benzylsulfanyl)methyl]benzene
HMS2270O24
FT-0624646
SCHEMBL206
benzyl sulfide [mi]
benzyl sulfide [hsdb]
benzyl sulphide
SCHEMBL11075647
(c6h5ch2)2s
dibenzylsulfane
((benzylthio)methyl)benzene
sulfide, dibenzyl-
CHEMBL1369381
STL482503
1,1'-(sulfanediyldimethanediyl)dibenzene
mfcd00004784
dibenzylsulfide
dibenzyl-sulfide
Q10374760
4-aminobenzoicacidhcl
D88649
dibenzylsulfid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (19)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency0.31620.044717.8581100.0000AID485294
LuciferasePhotinus pyralis (common eastern firefly)Potency39.81730.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency34.27140.006038.004119,952.5996AID1159521
ATAD5 protein, partialHomo sapiens (human)Potency25.91850.004110.890331.5287AID504467
AR proteinHomo sapiens (human)Potency28.88350.000221.22318,912.5098AID1259243; AID1259247
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency33.82800.001022.650876.6163AID1224838; AID1224839; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency43.50770.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency32.59740.003041.611522,387.1992AID1159552; AID1159553; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency27.22270.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.30850.000229.305416,493.5996AID743079
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency44.66840.707936.904389.1251AID504333
thyroid stimulating hormone receptorHomo sapiens (human)Potency28.04100.001628.015177.1139AID1224895; AID1259385
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency38.776319.739145.978464.9432AID1159509
chromobox protein homolog 1Homo sapiens (human)Potency50.11870.006026.168889.1251AID540317
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency44.66843.548119.542744.6684AID743266
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency31.62280.01789.637444.6684AID588834
histone deacetylase 9 isoform 3Homo sapiens (human)Potency24.26230.037617.082361.1927AID1259364
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.38040.000627.21521,122.0200AID743219
gemininHomo sapiens (human)Potency0.32640.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (15.38)18.7374
1990's2 (7.69)18.2507
2000's7 (26.92)29.6817
2010's7 (26.92)24.3611
2020's6 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.10 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index33.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]